Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) Equity Average (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed Equity Average for 15 consecutive years, with $182.6 million as the latest value for Q4 2025.

  • Quarterly Equity Average rose 15.31% to $182.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $182.6 million through Dec 2025, up 15.31% year-over-year, with the annual reading at $152.6 million for FY2025, 43.36% down from the prior year.
  • Equity Average hit $182.6 million in Q4 2025 for Mesa Laboratories, up from $175.5 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $409.5 million in Q1 2021 to a low of $148.1 million in Q2 2024.
  • Historically, Equity Average has averaged $306.6 million across 5 years, with a median of $383.9 million in 2022.
  • Biggest five-year swings in Equity Average: soared 79.9% in 2021 and later crashed 62.09% in 2024.
  • Year by year, Equity Average stood at $397.9 million in 2021, then decreased by 4.31% to $380.7 million in 2022, then rose by 3.85% to $395.4 million in 2023, then plummeted by 59.95% to $158.3 million in 2024, then increased by 15.31% to $182.6 million in 2025.
  • Business Quant data shows Equity Average for MLAB at $182.6 million in Q4 2025, $175.5 million in Q3 2025, and $166.2 million in Q2 2025.